AbbVie Inc. (ABBV) Q2 2018 Earnings Results

AbbVie Beats on EPS, Stock Down 3.6%

AbbVie's earnings report shows a small beat on EPS, indicating some operational strength. However, the stock fell by 3.6%, likely due to investor concerns about the lack of revenue details and no updated guidance. The market reaction suggests that investors are cautious about future performance amid ongoing challenges in the retail sector.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$2.00	N/A	+0.16%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed confidence in their strategic direction despite current market pressures. They emphasized the importance of innovation and pipeline development.

Management highlighted ongoing strength in key product lines.

They noted challenges in the market but remain focused on long-term growth.

AbbVie Beats on EPS, Stock Down 3.6%

Key numbers

Management commentary

AbbVie Inc.

More earnings this week

AbbVie Beats on EPS, Stock Down 3.6%

Key numbers

Management commentary